全球神經血管設備市場：到 2028 年的預測—按產品、應用、最終用戶和地區分析

根據 Stratistics MRC 的數據，2022 年全球神經血管器械市場規模將達到 27.6 億美元，預計到 2028 年將達到 50.6 億美元，預計將以 10.6 %的 CAGR 增長。

神經血管問題是用神經血管設備治療的。 神經血管疾病是由大腦的血液和氧氣供應不足或受限引起的，可導致嚴重殘疾甚至死亡。 這些包括中風、腦動脈瘤、動靜脈畸形和狹窄。 神經血管疾病的全球流行正在加速神經血管設備的市場。 神經學儀器通常用於診斷和治療大腦和中樞神經系統疾病。 隨著神經學技術的進步，對神經血管設備的需求也在增加。

根據腦動脈瘤基金會的數據，據信每年有 600 萬美國人患上腦動脈瘤。 此外，這種疾病每年在全世界造成 500,000 人死亡。 這些趨勢導致大量患者需要就醫。

市場動態

促進因素

腦出血增加

由於城市化進程加快、缺乏鍛煉和壓力等各種原因，全球中風的發病率正在上升。 這些變化正在產生大量需要醫療護理的患者。 這一點，以及患者對神經血管疾病治療和報銷意識的提高，特別是在新興市場，預計將在預測期內進一步加速神經血管設備市場的增長。 新興國家的政府和非營利組織對向公眾宣傳神經血管疾病的不同形式和症狀、緊急預防措施和可用的治療方法表現出了積極的興趣，這將有助於市場的發展。

抑制因素

嚴格的規定

限制神經血管設備全球市場的主要因素之一是神經血管手術和設備的高成本，尤其是在報銷制度寬鬆的新興國家。 此外，維護成本和其他間接成本增加了這些設備的總擁有成本，限制了它們的部署。 預算限制使得小型醫院和獨立的 ASC 難以購買昂貴且複雜的技術，這一問題在發展中國家更為突出。 在較貧窮的國家，由於費用高昂和報銷環境薄弱，很少有患者能夠獲得神經科治療。 因此，醫療機構不願花錢購買新穎、尖端的技術解決方案，從而限制了神經血管設備的市場。

機會

神經血管內裝置的保險範圍

在發達國家，中風治療的經濟負擔越來越重。 因此，這個國家對神經血管設備的接受度在很大程度上受到公共和私人健康保險覆蓋面的影響。 在亞太地區的新興國家，如中國和日本，政府和非政府組織正在採取措施完善和實施神經血管疾病治療的保險覆蓋政策。 預計這些因素將鼓勵更多人尋求治療並推動市場增長。

威脅

嚴格的規定

過去十年，Stryker 和 Medtronic Plc 等領先製造商已成功開發血管內神經治療設備並將其商業化。 這些產品主要用於海外的神經血管手術。 然而，在成熟國家，主要產品製造商因過去三年實施的不利政府改革而承受的價格壓力是影響全球神經產品開發管線的主要因素。

COVID-19 的影響

COVID-19 大流行對神經血管設備市場產生了負面影響，對每個行業的部門造成了乾擾、限制、困難和調整。 同樣，大流行也影響了神經血管設備行業。 例如，在外科手術過程中使用神經血管裝置。 因此，神經血管市場受到全球限制獲得 COVID-19 以外疾病醫療保健的負面影響。 此外，全球醫務人員供應有限是對神經血管設備市場產生負面影響的另一個因素。 因此，上述所有影響都阻礙了市場的增長。

栓塞器械細分市場預計在預測期內將成為最大的細分市場

由於廣泛的研發活動的增長、對微創手術的認識不斷提高以及栓塞產品和技術的技術進步，栓塞器械領域預計將實現良好增長。 近年來，各種疾病的患者選擇已轉向微創治療方法。 它也被認為比傳統的開放手術更安全，因為恢復時間更短。 栓塞也是一種微創技術，用於阻止血液流向異常組織腫瘤。 由於患者對微創栓塞手術的偏好不斷變化，市場正在擴大。 隨著微創手術需求的增加，栓塞市場預計將促進神經血管設備市場的增長。

在預測期內，缺血性中風部分預計將見證最高的複合年增長率

在預測期內，缺血性中風部分預計將以最快的複合年增長率增長。 隨著缺血性中風患病率的普遍增加以及治療這種疾病的新技術的可用性，預計將推動用於介入神經病學的神經血管設備的市場擴張。 據美國疾病控制和預防中心稱，大約 87% 的中風是由腦血流停滯引起的。 美國心臟協會還建議使用支架取出工具去除凝塊，這樣患者就不會遭受缺血性中風。 因此，隨著缺血患者數量的增加，預計在預測期內對神經血管設備的需求將會增加。

市場份額最高的地區

由於患有神經血管疾病的老年人數量迅速增加，預計亞太地區在預測期內將佔據最大的市場份額。 例如，亞太地區的老齡化人口正以前所未有的速度增長，預計到 2050 年該地區四分之一的人口將超過 60 歲。 這要歸功於聯合國人口基金。 此外，由於日本、中國和印度等多個國家的新興市場，亞太地區的市場有望增長。 醫療保健基礎設施的擴大和神經血管疾病患病率的上升，預計亞太地區的市場將出現大幅增長。

複合年增長率最高的地區

由於神經血管疾病發病率上升以及對微創手術的強勁需求，預計歐洲在預測期內的複合年增長率最高。 例如，美國疾病控制和預防中心估計，歐洲每年發生超過 795,000 例中風，約佔所有中風的 87%。 此外，由於醫療成本上升以及德國、法國和意大利等國家廣泛使用技術先進的系統，神經介入設備的使用預計在預測期內會增加，從而推動市場增長。

主要發展

2022 年 12 月，全球最大、最多元化的醫療保健產品公司強生公司今天宣布已完成對 Abiomed 的收購。 Abiomed 現在是強生公司的一部分，並將作為強生公司醫療技術部門的一個獨立業務部門運營。

2022 年 12 月，強生旗下楊森製藥公司公佈了 DARZARLEX (daratumumab) 聯合來那度胺和地塞米松 (D-Rd) 的 3 期 MAIA 研究的新分析結果，無進展生存期 (PFS)、最小殘留介紹了中位隨訪時疾病 (MRD) 陰性和總體緩解率 (ORR)。

2022 年 12 月，強生公司公佈了在研、即用型雙特異性 T 細胞接合抗體 tarquetamab 的 1/2 期 MonumentTAL-1 研究的最新結果。 Talquetamab 靶向多發性骨髓瘤細胞的新靶點 GPRC5D 和 T 細胞上的 CD3，推動人體免疫系統來對抗這種血癌。

2022 年 12 月，美敦力 (Medtronic) 宣佈在美國進行 HUGO(TM) 機器人手術系統 HUGO(TM) RAS 系統臨床試驗的首位患者招募根治性膀胱切除術和腎切除術（部分或根治性）手術。

本報告的內容

• 區域和國家級細分市場的市場份額評估
• 向新進入者提出戰略建議
• 2020、2021、2022、2025 和 2028 年的綜合市場數據
• 涵蓋市場趨勢（市場促進因素、促進因素、機遇、威脅、挑戰、投資機會、建議）
• 根據市場預測在關鍵業務領域提出戰略建議
• 競爭格局映射主要共同趨勢
• 公司簡介，包括詳細的戰略、財務狀況和近期發展
• 映射最新技術進步的供應鏈趨勢

免費定制服務

訂閱此報告的客戶將免費獲得以下自定義選項之一

• 公司簡介
  • 其他市場參與者的綜合概況（最多 3 家公司）
  • 主要參與者的 SWOT 分析（最多 3 家公司）
• 區域細分
  • 根據客戶要求對主要國家/地區的市場進行估算、預測和復合年增長率（注意：基於可行性檢查）
• 競爭基準
  • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

內容

第 1 章內容提要

第 2 章前言

• 概覽
• 利益相關者
• 調查範圍
• 調查方法
  • 數據挖掘
  • 數據分析
  • 數據驗證
  • 研究方法
• 調查來源
  • 主要研究資訊來源
  • 二次研究資訊來源
  • 假設

第 3 章市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 產品分析
• 應用分析
• 最終用戶分析
• 新興市場
• COVID-19 的影響

第 4 章波特五力分析

• 供應商的議價能力
• 買家的議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第 5 章全球神經血管設備市場：按產品分類

• 腦球囊血管成形術
• 動脈瘤捲繞術
• 神經取栓裝置
• 支持的設備
• 支架放置系統
• 栓塞裝置
• 其他產品

第 6 章全球神經血管設備市場：按應用

• 缺血性中風
• 腦動脈瘤
• 頸動脈狹窄
• 動靜脈畸形和瘺管

第 7 章全球神經血管設備市場：按最終用戶分類

• 醫院
• 專科診所
• 門診中心
• 其他最終用戶

第 8 章全球神經血管設備市場：按地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 意大利
  • 法國
  • 西班牙
  • 其他歐洲
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳大利亞
  • 新西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 其他南美洲
• 中東和非洲
  • 沙特阿拉伯
  • 阿拉伯聯合酋長國
  • 卡塔爾
  • 南非
  • 其他中東地區

第 9 章主要進展

• 合同、夥伴關係、協作和合資企業
• 收購與合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第 10 章公司簡介

• Johnson & Johnson Services, Inc.
• Medtronic
• Penumbra, Inc.
• Terumo Corporation
• MicroPort Scientific Corporation
• Shape Memory Medical
• Imperative Care
• Integer Holdings Corporation
• ASAHI INTECC CO., LTD.
• Stryker
• Microvention Inc
• Codman Neuro
• Merit Medical Systems
• W.L.Gore & Associates, Inc
• Acandis GmbH

According to Stratistics MRC, the Global Neurovascular Devices Market is accounted for $2.76 billion in 2022 and is expected to reach $5.06 billion by 2028 growing at a CAGR of 10.6% during the forecast period. Neurovascular problems are treated with neurovascular devices. The neurovascular illnesses might cause the patient to experience significant disability or perhaps pass away because they are brought on by inadequate or constrained blood and oxygen supply to the brain. Strokes, brain aneurysms, arteriovenous malformations, and stenosis can result from this. The global prevalence of neurovascular illnesses is driving acceleration in the market for neurovascular devices. In order to diagnose and treat disorders of the brain and central nervous system, neurological gadgets are routinely utilised. Because of advances in technology in neurology, there is a growing demand for neurovascular devices.

According to the Brain Aneurysm Foundation, 6 million Americans are thought to experience brain aneurysms annually. Additionally, every year, the illness kills half a million people worldwide. These trends are creating a sizable patient population that needs medical attention.

Market Dynamics:

Driver:

Rise in the number of strokes

The incidence of strokes worldwide has been rising as a result of a number of causes, including growing urbanisation, an inactive lifestyle and stress. Such changes are creating a huge patient population that needs medical attention. This is expected to further accelerate the growth of the neurovascular devices market during the projected period, along with rising patient awareness regarding the accessibility of treatment and reimbursement for neurovascular illnesses, particularly in emerging nations. Governments and non-profit organizations from developing nations are actively interested in educating the general public about the different forms of neurovascular illnesses, their symptoms, the precautions to take in an emergency, and the available treatments which are accelerating the market growth.

Restraint:

Strict regulations

One of the main factors limiting the global market for neurovascular devices is the high cost of neurovascular surgical procedures and equipment, particularly in developing nations with lax reimbursement systems. Additionally, the total cost of ownership of these devices rises due to maintenance costs and other related indirect costs, which restricts their adoption. Budgetary restrictions make it more difficult for small hospitals and independent ASCs to purchase expensive and complex technologies this problem is more pronounced in developing nations. Only a very small number of patients in impoverished nations can afford neurological treatment due to exorbitant costs and a weak reimbursement environment. As a result, healthcare facilities are hesitant to spend money on novel or cutting-edge technical solutions, which restricts the market for neurovascular devices.

Opportunity:

Insurance Coverage for Neurovascular Devices

Patients have a heavy financial burden for stroke treatment in developed countries. Therefore, the acceptance of neurovascular devices in this country has been greatly influenced by the availability of insurance coverage through public and private health insurance. Government and non-government groups have taken steps to improve and execute insurance coverage policies for the treatment of neurovascular illnesses in rising Asia-Pacific nations like China and Japan. It is anticipated that this factor would result in more people receiving therapy encouraging the market growth.

Threat:

Strict regulations

Various major producers of neurovascular devices, including Stryker and Medtronic Plc, have had success in the previous ten years with the creation and subsequent commercialization of their individual products. These goods were primarily made for usage abroad during neurovascular operations. However, in mature countries, pricing pressure experienced by the major product makers as a result of unfavourable government reforms implemented in the previous three years is the principal factor affecting the development pipeline for worldwide neurology goods.

COVID-19 Impact

The COVID-19 pandemic has had a negative impact on the neurovascular devices market which caused disruption, constraints, difficulties, and adjustments in every industry's sector. Similar to this, the pandemic also had an effect on the neurovascular devices industry. Neurovascular devices, for instance, are employed during surgical procedures. As a result, the neurovascular market has been negatively impacted by the limited accessibility of medical care for disorders other than COVID-19 globally. Another component that has an adverse impact on the market for neurovascular devices is the restricted supply of healthcare workers globally. Thus all the above impacts have hampered the market growth.

The embolization devices segment is expected to be the largest during the forecast period

The embolization devices segment is estimated to have a lucrative growth, due to the extensive R&D activity growth, increased awareness in less invasive procedures, and technological advancements in embolization products and techniques. Patients' choices for various diseases are shifting in recent years to choose minimally invasive therapies. Moreover, since the recovery time is less than with conventional open procedures, it is safer. Embolization is another minimally invasive technique used to stop the blood flow to abnormal tissue tumours. The market is growing as a result of patients' changing preferences toward less invasive embolization. The market for embolization is predicted to grow as demand for minimally invasive procedures increases in turn helps in growth of the neurovascular devices market.

The ischemic stroke segment is expected to have the highest CAGR during the forecast period

The ischemic stroke segment is anticipated to witness the fastest CAGR growth during the forecast period; due to the widespread increase in the prevalence of ischemic stroke and the accessibility of novel technologies for the condition's treatment and aspects that are expected to drive the market expansion for neurovascular devices used in interventional neurology. About 87% of strokes, according to the Centers for Disease Control and Prevention, are brought on by a blockage in cerebral blood flow. The American Heart Association also suggests using stent retrieval tools to remove blood clots from patients to help patients avoid having an ischemic stroke. Thus, it is projected that during the forecast period, demand for neurovascular devices will increase as ischemia cases rise.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the number of geriatrics with neurovascular diseases is growing quickly. For instance, the Asia Pacific region's geriatric population is growing at an unprecedented rate, and it is predicted that by 2050, one in four persons in this region would be over 60. This is according to the United Nations Population Fund. Additionally, the Asia Pacific market is anticipated to increase as a result of the emerging markets in various nations, including Japan, China, and India. Due to the expanding health care infrastructure and rising prevalence of neurovascular diseases, Asia pacific region is anticipated to show considerable market growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the rising incidence of neurovascular disorders and the strong demand for minimally invasive procedures. For instance, the Centers for Disease Control and Prevention estimate that more than 795,000 strokes, or approximately 87% of all strokes, occur in the Europe each year. In addition, it is anticipated that the use of neuro interventional devices would increase over the course of the projection period due to rising healthcare costs and the widespread use of technologically sophisticated systems in nations like Germany, France and Italy regions are propelling the market growth.

Key players in the market

Some of the key players profiled in the Neurovascular Devices Market include Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc, Terumo Corporation, MicroPort Scientific Corporation, Shape Memory Medical, Imperative Care, Integer Holdings Corporation, ASAHI INTECC CO., LTD, Stryker, Microvention Inc, Codman Neuro, Merit Medical Systems, W.L.Gore & Associates, Inc and Acandis GmbH.

Key Developments:

In Dec 2022, Johnson & Johnson the world's largest, most diversified healthcare products company, today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson's MedTech segment.

In Dec 2022, The Janssen Pharmaceutical Companies of Johnson & Johnson announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow up.

In Dec 2022, the Johnson & Johnson announced updated results from the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf (ready to use), bispecific T-cell engager antibody. Talquetamab targets both GPRC5D, a novel target on multiple myeloma cells, and CD3 on T cells, activating the body's immune system to fight this blood cancer.

In Dec 2022, Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system the Hugo™ RAS system is intended to be used in this study for urologic surgical procedures including radical prostatectomy, radical cystectomy, and nephrectomy (partial or radical) procedures at sites in the U.S.

Products Covered:

• Cerebral Balloon Angioplasty
• Aneurysm Coiling
• Neurothrombectomy Devices
• Support Devices
• Stenting Systems
• Embolization Devices
• Other Products

Applications Covered:

• Ischemic Stroke
• Cerebral Aneuryms
• Carotid Artery Stenosis
• Arteriovenous Malformations & Fistulas

End Users Covered:

• Hospitals
• Speciality Clinics
• Ambulatory Care Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Neurovascular Devices Market, By Product

• 5.1 Introduction
• 5.2 Cerebral Balloon Angioplasty
• 5.3 Aneurysm Coiling
• 5.4 Neurothrombectomy Devices
• 5.5 Support Devices
• 5.6 Stenting Systems
• 5.7 Embolization Devices
• 5.8 Other Products

6 Global Neurovascular Devices Market, By Application

• 6.1 Introduction
• 6.2 Ischemic Stroke
• 6.3 Cerebral Aneuryms
• 6.4 Carotid Artery Stenosis
• 6.5 Arteriovenous Malformations & Fistulas

7 Global Neurovascular Devices Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Speciality Clinics
• 7.4 Ambulatory Care Centers
• 7.5 Other End Users

8 Global Neurovascular Devices Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Johnson & Johnson Services, Inc.
• 10.2 Medtronic
• 10.3 Penumbra, Inc.
• 10.4 Terumo Corporation
• 10.5 MicroPort Scientific Corporation
• 10.6 Shape Memory Medical
• 10.7 Imperative Care
• 10.8 Integer Holdings Corporation
• 10.9 ASAHI INTECC CO., LTD.
• 10.10 Stryker
• 10.11 Microvention Inc
• 10.12 Codman Neuro
• 10.13 Merit Medical Systems
• 10.14 W.L.Gore & Associates, Inc
• 10.15 Acandis GmbH

List of Tables

• 1 Global Neurovascular Devices Market Outlook, By Region (2020-2028) ($MN)
• 2 Global Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
• 3 Global Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
• 4 Global Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
• 5 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
• 6 Global Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
• 7 Global Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
• 8 Global Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
• 9 Global Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
• 10 Global Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
• 11 Global Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
• 12 Global Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
• 13 Global Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
• 14 Global Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
• 15 Global Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
• 16 Global Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
• 17 Global Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
• 18 Global Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
• 19 Global Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
• 20 North America Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
• 21 North America Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
• 22 North America Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
• 23 North America Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
• 24 North America Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
• 25 North America Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
• 26 North America Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
• 27 North America Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
• 28 North America Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
• 29 North America Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
• 30 North America Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
• 31 North America Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
• 32 North America Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
• 33 North America Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
• 34 North America Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
• 35 North America Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
• 36 North America Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
• 37 North America Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
• 38 North America Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
• 39 Europe Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
• 40 Europe Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
• 41 Europe Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
• 42 Europe Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
• 43 Europe Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
• 44 Europe Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
• 45 Europe Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
• 46 Europe Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
• 47 Europe Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
• 48 Europe Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
• 49 Europe Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
• 50 Europe Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
• 51 Europe Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
• 52 Europe Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
• 53 Europe Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
• 54 Europe Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
• 55 Europe Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
• 56 Europe Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
• 57 Europe Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
• 58 Asia Pacific Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
• 59 Asia Pacific Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
• 60 Asia Pacific Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
• 61 Asia Pacific Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
• 62 Asia Pacific Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
• 63 Asia Pacific Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
• 64 Asia Pacific Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
• 65 Asia Pacific Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
• 66 Asia Pacific Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
• 67 Asia Pacific Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
• 68 Asia Pacific Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
• 69 Asia Pacific Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
• 70 Asia Pacific Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
• 71 Asia Pacific Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
• 72 Asia Pacific Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
• 73 Asia Pacific Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
• 74 Asia Pacific Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
• 75 Asia Pacific Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
• 76 Asia Pacific Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
• 77 South America Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
• 78 South America Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
• 79 South America Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
• 80 South America Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
• 81 South America Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
• 82 South America Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
• 83 South America Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
• 84 South America Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
• 85 South America Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
• 86 South America Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
• 87 South America Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
• 88 South America Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
• 89 South America Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
• 90 South America Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
• 91 South America Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
• 92 South America Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
• 93 South America Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
• 94 South America Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
• 95 South America Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
• 96 Middle East & Africa Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
• 97 Middle East & Africa Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
• 98 Middle East & Africa Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
• 99 Middle East & Africa Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
• 100 Middle East & Africa Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
• 101 Middle East & Africa Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
• 102 Middle East & Africa Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
• 103 Middle East & Africa Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
• 104 Middle East & Africa Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
• 105 Middle East & Africa Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
• 106 Middle East & Africa Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
• 107 Middle East & Africa Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
• 108 Middle East & Africa Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
• 109 Middle East & Africa Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
• 110 Middle East & Africa Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
• 111 Middle East & Africa Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
• 112 Middle East & Africa Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
• 113 Middle East & Africa Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
• 114 Middle East & Africa Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)